Lactose (India) Ltd | 142 Cr. | 101 | 247/84.3 | 27.6 | 41.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
MPS Pharmaa Ltd | 5.27 Cr. | 2.76 | 4.33/2.50 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 41.6 Cr. | 56.0 | 94.9/44.5 | | 8.73 | 0.00 % | 41.5 % | 14.4 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 32.1 Cr. | 21.9 | 29.1/13.1 | 31.4 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 71.5 Cr. | 95.0 | 155/79.0 | 16.3 | 57.6 | 0.00 % | 10.3 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 47,125 Cr. | 1,670 | 1,831/1,199 | 35.8 | 314 | 0.15 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 296 Cr. | 13.0 | 29.0/11.2 | 18.3 | 8.21 | 0.00 % | 12.5 % | 9.03 % | 1.00 |
Ganga Pharmaceuticals Ltd | 6.44 Cr. | 13.3 | 27.1/9.25 | 80.5 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 384 Cr. | 814 | 956/635 | 18.5 | 299 | 0.09 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 90.7 Cr. | 20.7 | 32.0/14.6 | 30.8 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 995 Cr. | 338 | 449/163 | 13.0 | 123 | 0.37 % | 21.7 % | 23.4 % | 5.00 |
Fabino Enterprises Ltd | 5.20 Cr. | 24.8 | 36.5/22.8 | 40.0 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 11.7 Cr. | 4.69 | 12.3/2.11 | 130 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 391 Cr. | 402 | 477/112 | | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,192 Cr. | 1,193 | 1,584/1,015 | 54.8 | 396 | 0.00 % | 8.72 % | 5.64 % | 10.0 |
Murae Organisor Ltd | 218 Cr. | 1.17 | 1.37/0.53 | 28.9 | 1.12 | 0.00 % | 4.21 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 53.0 Cr. | 22.0 | 26.3/6.40 | 63.9 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 11.4 Cr. | 11.3 | 20.7/9.61 | | 22.6 | 0.00 % | 28.4 % | 22.7 % | 10.0 |
Coral Laboratories Ltd | 214 Cr. | 600 | 999/571 | 8.66 | 563 | 0.33 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 30.4 Cr. | 30.4 | 45.0/26.1 | 101 | 34.1 | 0.00 % | 4.83 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 25.4 Cr. | 55.5 | 88.7/40.2 | 50.7 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 10.3 Cr. | 4.12 | 26.2/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 18.4 Cr. | 123 | 154/55.1 | 54.3 | 87.6 | 0.00 % | 3.78 % | 2.62 % | 10.0 |
Checkpoint Trends Ltd | 11.5 Cr. | 21.1 | 28.9/6.08 | 384 | 1.02 | 0.00 % | 9.17 % | 5.50 % | 10.0 |
Chandra Bhagat Pharma Ltd | 44.1 Cr. | 58.5 | 101/46.2 | 51.3 | 39.7 | 0.00 % | 6.48 % | 2.92 % | 10.0 |
Brawn Biotech Ltd | 5.10 Cr. | 17.0 | 27.8/15.5 | | 11.2 | 0.00 % | 42.5 % | 42.8 % | 10.0 |
Blue Jet Healthcare Ltd | 16,544 Cr. | 954 | 986/385 | 54.2 | 65.3 | 0.10 % | 40.6 % | 30.8 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 109 Cr. | 25.4 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 10.1 Cr. | 20.0 | 46.0/17.4 | 17.5 | 18.7 | 0.00 % | 10.1 % | 6.30 % | 10.0 |
BDH Industries Ltd | 152 Cr. | 264 | 418/241 | 16.4 | 119 | 1.70 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 23.2 Cr. | 39.5 | 62.6/14.8 | 58.1 | 43.2 | 0.00 % | 3.05 % | 3.00 % | 10.0 |
Aurobindo Pharma Ltd | 67,395 Cr. | 1,150 | 1,593/994 | 19.4 | 557 | 0.39 % | 14.3 % | 11.2 % | 1.00 |
Auro Laboratories Ltd | 170 Cr. | 273 | 300/156 | 92.5 | 69.0 | 0.00 % | 3.79 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 1,082 Cr. | 216 | 250/148 | 22.8 | 65.1 | 1.16 % | 19.5 % | 15.3 % | 5.00 |
ANG Lifesciences India Ltd | 39.2 Cr. | 30.0 | 62.8/21.0 | | 51.2 | 0.00 % | 4.12 % | 14.4 % | 10.0 |
Ami Organics Ltd | 9,630 Cr. | 1,176 | 1,322/504 | 60.7 | 160 | 0.13 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 5.68 Cr. | 0.86 | 1.45/0.58 | 568 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 279 Cr. | 36.4 | 77.7/34.1 | 27.8 | 18.3 | 0.00 % | 8.60 % | 7.23 % | 10.0 |
Adline Chem Lab Ltd | 9.99 Cr. | 17.1 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 82.0 Cr. | 3.48 | 6.25/2.82 | 149 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 66,969 Cr. | 31,515 | 32,229/25,260 | 47.4 | 1,992 | 1.51 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 8,027 Cr. | 886 | 950/521 | 29.5 | 220 | 0.34 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 157 Cr. | 55.3 | 75.8/31.3 | 39.0 | 48.8 | 0.00 % | 6.00 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 2,835 Cr. | 963 | 1,078/535 | | 78.1 | 0.10 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 28,861 Cr. | 1,776 | 1,870/552 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 1,023 Cr. | 312 | 330/151 | 33.5 | 18.1 | 0.00 % | 34.9 % | 70.0 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.11 % | % | 2.00 |
Venus Remedies Ltd | 611 Cr. | 457 | 477/270 | 15.6 | 420 | 0.00 % | 11.4 % | 7.45 % | 10.0 |
Unichem Laboratories Ltd | 4,267 Cr. | 606 | 950/510 | 31.0 | 348 | 0.00 % | 6.36 % | 5.71 % | 2.00 |
TTK Healthcare Ltd | 1,800 Cr. | 1,274 | 1,923/991 | 25.3 | 754 | 0.79 % | 9.25 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,10,074 Cr. | 3,252 | 3,591/2,755 | 57.1 | 224 | 0.98 % | 27.2 % | 26.7 % | 5.00 |
Themis Medicare Ltd | 1,268 Cr. | 138 | 317/115 | 42.5 | 43.7 | 0.36 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 2,021 Cr. | 21.5 | 27.9/12.3 | 41.4 | 3.62 | 0.00 % | 18.7 % | 15.6 % | 1.00 |
Suven Pharmaceuticals Ltd | 27,473 Cr. | 1,079 | 1,360/597 | 98.5 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 5,147 Cr. | 236 | 272/95.2 | | 5.04 | 0.00 % | 84.4 % | 84.6 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,04,960 Cr. | 1,688 | 1,960/1,461 | 35.3 | 301 | 0.95 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,238 Cr. | 505 | 886/417 | 4,145 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,195 Cr. | 248 | 398/175 | 32.1 | 75.9 | 0.16 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 351 Cr. | 1,160 | 1,750/765 | 18.7 | 650 | 0.13 % | 11.8 % | 10.0 % | 10.0 |
Shilpa Medicare Ltd | 9,640 Cr. | 986 | 996/518 | 108 | 243 | 0.00 % | 7.94 % | 4.28 % | 1.00 |
Sequent Scientific Ltd | 4,937 Cr. | 197 | 241/111 | 223 | 28.1 | 0.00 % | 8.97 % | 3.25 % | 2.00 |
Sanofi India Ltd | 14,158 Cr. | 6,148 | 7,600/4,146 | 37.3 | 374 | 1.90 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,873 Cr. | 2,342 | 2,977/1,457 | 32.8 | 321 | 0.68 % | 33.3 % | 26.1 % | 8.00 |
Procter & Gamble Health Ltd | 9,679 Cr. | 5,831 | 6,176/4,863 | 37.2 | 323 | 1.37 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 204 Cr. | 58.0 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 26,911 Cr. | 5,882 | 6,453/3,701 | 42.1 | 922 | 0.59 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 120 Cr. | 97.8 | 348/81.0 | 9.01 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 2,762 Cr. | 451 | 582/130 | | 136 | 0.00 % | 4.68 % | 5.03 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,622 Cr. | 714 | 1,998/604 | 36.3 | 250 | 0.00 % | 8.02 % | 8.18 % | 10.0 |
Neuland Laboratories Ltd | 16,926 Cr. | 13,193 | 18,100/6,378 | 83.5 | 1,188 | 0.09 % | 18.2 % | 14.4 % | 10.0 |
Nectar Lifescience Ltd | 526 Cr. | 23.4 | 56.5/20.0 | 30.9 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 16,347 Cr. | 913 | 1,639/660 | 8.68 | 425 | 1.04 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 3,544 Cr. | 64.7 | 101/41.7 | 30.0 | 21.1 | 0.00 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 11,748 Cr. | 259 | 359/157 | 30.9 | 54.4 | 0.23 % | 20.1 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 128 Cr. | 80.7 | 145/70.1 | 18.4 | 93.9 | 0.00 % | 8.20 % | 4.76 % | 10.0 |
Lyka Labs Ltd | 412 Cr. | 116 | 177/90.2 | 52.0 | 29.0 | 0.00 % | 9.93 % | 9.24 % | 10.0 |
Lupin Ltd | 91,321 Cr. | 2,000 | 2,403/1,531 | 27.8 | 377 | 0.40 % | 21.5 % | 20.8 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,174 Cr. | 586 | 980/499 | 14.2 | 335 | 0.31 % | 17.6 % | 13.0 % | 10.0 |
Laurus Labs Ltd | 35,947 Cr. | 667 | 681/390 | 106 | 84.6 | 0.18 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 1,067 Cr. | 1,029 | 1,070/481 | 26.8 | 256 | 0.00 % | 18.3 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 189 Cr. | 87.8 | 129/63.6 | | 67.8 | 0.00 % | 29.9 % | % | 10.0 |
Kopran Ltd | 949 Cr. | 196 | 370/155 | 24.6 | 107 | 1.53 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 731 Cr. | 454 | 500/271 | 29.3 | 126 | 0.00 % | 17.3 % | 13.2 % | 10.0 |
Jubilant Pharmova Ltd | 17,431 Cr. | 1,094 | 1,310/701 | 31.4 | 393 | 0.46 % | 9.54 % | 9.50 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 27,052 Cr. | 1,734 | 2,030/1,303 | 41.0 | 221 | 0.71 % | 26.6 % | 20.8 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,548 Cr. | 233 | 328/126 | 39.0 | 36.1 | 0.86 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 34,717 Cr. | 1,368 | 1,758/1,052 | 40.0 | 274 | 0.29 % | 15.0 % | 13.1 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,605 Cr. | 88.8 | 108/57.5 | 25.8 | 57.5 | 1.13 % | 8.85 % | 6.12 % | 2.00 |
Ind-Swift Ltd | 94.5 Cr. | 17.4 | 34.7/12.0 | 1.47 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 658 Cr. | 109 | 186/67.2 | 7.96 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,589 Cr. | 281 | 388/190 | | 111 | 0.53 % | 0.48 % | 7.00 % | 2.00 |
Hikal Ltd | 4,634 Cr. | 376 | 465/294 | 51.0 | 102 | 0.32 % | 9.87 % | 7.41 % | 2.00 |
Hester Biosciences Ltd | 1,581 Cr. | 1,859 | 3,379/1,243 | 57.5 | 369 | 0.32 % | 9.62 % | 9.07 % | 10.0 |
Gufic BioSciences Ltd | 3,717 Cr. | 371 | 504/285 | 53.2 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 12,355 Cr. | 509 | 725/412 | 25.8 | 153 | 0.29 % | 15.1 % | 13.8 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 47,125 Cr. | 1,670 | 1,831/1,199 | 35.8 | 314 | 0.15 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 55,819 Cr. | 3,295 | 3,516/1,921 | 63.9 | 115 | 1.27 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 27,839 Cr. | 1,690 | 2,221/1,200 | 25.6 | 592 | 1.18 % | 15.9 % | 11.6 % | 1.00 |
FDC Ltd | 7,747 Cr. | 476 | 659/359 | 29.0 | 140 | 1.05 % | 16.4 % | 12.2 % | 1.00 |
ERIS Lifesciences Ltd | 24,449 Cr. | 1,795 | 1,910/987 | 69.5 | 210 | 0.41 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,13,702 Cr. | 1,362 | 1,421/1,020 | 20.1 | 402 | 0.59 % | 23.1 % | 18.3 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,383 Cr. | 280 | 308/155 | | 372 | 0.00 % | 2.44 % | 0.34 % | 2.00 |
Cipla Ltd | 1,21,574 Cr. | 1,505 | 1,702/1,310 | 23.1 | 386 | 0.86 % | 23.3 % | 18.2 % | 2.00 |
Caplin Point Laboratories Ltd | 16,269 Cr. | 2,140 | 2,641/1,365 | 30.3 | 375 | 0.23 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 370 Cr. | 126 | 203/82.0 | | 33.3 | 0.00 % | 9.90 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,573 Cr. | 149 | 186/101 | 18.7 | 99.7 | 0.33 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 81.6 Cr. | 50.1 | 92.0/40.4 | 146 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 42,669 Cr. | 355 | 405/291 | 44.4 | 180 | 0.14 % | 6.13 % | 4.64 % | 5.00 |
Beta Drugs Ltd | 1,827 Cr. | 1,810 | 2,215/1,119 | 39.9 | 195 | 0.00 % | 27.3 % | 25.8 % | 10.0 |
Bal Pharma Ltd | 165 Cr. | 103 | 158/76.3 | 22.8 | 48.6 | 1.16 % | 10.1 % | 9.84 % | 10.0 |
Bafna Pharmaceuticals Ltd | 176 Cr. | 74.5 | 96.0/67.8 | 28.0 | 35.8 | 0.00 % | 8.28 % | 7.61 % | 10.0 |
Astrazeneca Pharma India Ltd | 26,274 Cr. | 10,510 | 10,691/6,070 | 150 | 308 | 0.23 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,011 Cr. | 695 | 863/544 | 39.6 | 113 | 0.66 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 208 Cr. | 99.1 | 145/82.2 | 10.6 | 86.4 | 0.00 % | 15.0 % | 11.4 % | 10.0 |
Alkem Laboratories Ltd | 57,959 Cr. | 4,848 | 6,440/4,492 | 26.8 | 1,002 | 0.83 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 19,639 Cr. | 999 | 1,304/725 | 34.4 | 264 | 1.10 % | 13.1 % | 11.4 % | 2.00 |
Albert David Ltd | 493 Cr. | 863 | 1,754/763 | 28.6 | 688 | 0.58 % | 6.48 % | 4.44 % | 10.0 |
Ajanta Pharma Ltd | 32,904 Cr. | 2,634 | 3,486/2,022 | 35.8 | 290 | 1.37 % | 33.3 % | 25.6 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,587 Cr. | 321 | 571/258 | 27.4 | 127 | 1.62 % | 13.0 % | 9.55 % | 2.00 |
Aarti Drugs Limited | 4,263 Cr. | 464 | 635/312 | 27.1 | 136 | 0.22 % | 13.4 % | 13.0 % | 10.0 |
Industry Average | 18,969.32 Cr | 1,189.27 | | 92.44 | 194.72 | 0.31% | 16.67% | 15.20% | 6.18 |